Article Details

Galera Therapeutics Raises $150 Million for GC4419 Phase 3 Trial and Pre-Commercialization ...

Retrieved on: 2018-09-18 19:26:15

Tags for this article:

Click the tags to see associated articles and topics

Galera Therapeutics Raises $150 Million for GC4419 Phase 3 Trial and Pre-Commercialization .... View article details on hiswai:

Excerpt

<div>Existing investors Correlation Ventures, Galera Angels, <b>New Enterprise</b> <b>Associates</b>, Novartis Venture Fund, Novo Ventures and Sofinnova Ventures ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up